
Radius Heal is a drug manufacturers-specialty & generic business based in the US. Radius Heal shares (RDUS) are listed on the NASDAQ and all prices are listed in US Dollars. Radius Heal employs 293 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Radius Heal
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RDUS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Radius Heal stock price (NASDAQ: RDUS)
Use our graph to track the performance of RDUS stocks over time.Radius Heal shares at a glance
Latest market close | $10.48 |
---|---|
52-week range | $4.97 - $23.00 |
50-day moving average | $7.17 |
200-day moving average | $10.11 |
Wall St. target price | $9.60 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.54 |
Buy Radius Heal shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Radius Heal stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Radius Heal price performance over time
Historical closes compared with the close of $10.48 from 2022-07-01
1 week (2022-06-28) | -0.19% |
---|---|
1 month (2022-06-01) | N/A |
3 months (2022-04-05) | 20.18% |
6 months (2022-01-05) | 67.41% |
1 year (2021-07-02) | -41.29% |
---|---|
2 years (2020-07-02) | -26.04% |
3 years (2019-07-05) | 24.62 |
5 years (2017-07-03) | 45.95 |
Radius Heal financials
Revenue TTM | $216.9 million |
---|---|
Gross profit TTM | $211.6 million |
Return on assets TTM | -17.8% |
Return on equity TTM | 0% |
Profit margin | -33.52% |
Book value | $0.00 |
Market capitalisation | $493.6 million |
TTM: trailing 12 months
Radius Heal share dividends
We're not expecting Radius Heal to pay a dividend over the next 12 months.
Have Radius Heal's shares ever split?
Radius Heal's shares were split on a 25:57 basis on 23 April 2014. So if you had owned 57 shares the day before before the split, the next day you'd have owned 25 shares. This wouldn't directly have changed the overall worth of your Radius Heal shares – just the quantity. However, indirectly, the new 128% higher share price could have impacted the market appetite for Radius Heal shares which in turn could have impacted Radius Heal's share price.
Radius Heal share price volatility
Over the last 12 months, Radius Heal's shares have ranged in value from as little as $4.97 up to $23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Radius Heal's is 1.0336. This would suggest that Radius Heal's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Radius Heal overview
Radius Health, Inc. , a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd. ; and Duke University.
Radius Heal in the news
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HMLP, CTT, RADA, RDUS
Radius (RDUS) to Go Private With $890M Deal, Shares Gain

Velan-Repertoire Comments on Proposed Sale of Radius Health to Gurnet Point Capital and Patient Square Capital
Frequently asked questions
What percentage of Radius Heal is owned by insiders or institutions?Currently 0.525% of Radius Heal shares are held by insiders and 117.335% by institutions. How many people work for Radius Heal?
Latest data suggests 293 work at Radius Heal. When does the fiscal year end for Radius Heal?
Radius Heal's fiscal year ends in December. Where is Radius Heal based?
Radius Heal's address is: 22 Boston Wharf Road, Boston, MA, United States, 02210 What is Radius Heal's ISIN number?
Radius Heal's international securities identification number is: US7504692077 What is Radius Heal's CUSIP number?
Radius Heal's Committee on Uniform Securities Identification Procedures number is: 750469207
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert